Long-term remission of disseminated parathyroid cancer following immunotherapy

Marta Sarquis; Stephen J. Marx; Albert Beckers; Arthur R. Bradwell; William F. Simonds; Maria Aparecida C. Bicalho; Adrian F. Daly; Daniela Betea; Eitan Friedman; Luiz De Marco

doi:10.1007/s12020-019-02136-z

Long-term remission of disseminated parathyroid cancer following immunotherapy

Marta Sarquis
, Stephen J. Marx
, Albert Beckers
, Arthur R. Bradwell
, William F. Simonds
, Maria Aparecida C. Bicalho
, Adrian F. Daly
, Daniela Betea
, Eitan Friedman
, Luiz De Marco^*

^*Corresponding author for this work

Universidade Federal de Minas Gerais
National Institutes of Health
University of Liege
University of Birmingham
Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Abstract

Purpose: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered. Subject and results: A patient with CDC73-associated metastatic parathyroid carcinoma was treated with combined anti-hPTH immunotherapy and surgery. Conclusions: Following five courses of anti-hPTH immunotherapy and subsequent surgery, a 12-year long remission of disseminated parathyroid cancer is reported. This case further supports the ever-expanding spectrum of cancers that may benefit from immunotherapy.

Original language	English
Pages (from-to)	204-208
Number of pages	5
Journal	Endocrine
Volume	67
Issue number	1
DOIs	https://doi.org/10.1007/s12020-019-02136-z
State	Published - 1 Jan 2020
Externally published	Yes

Funding

Funders	Funder number
National Institutes of Health	F05TW002013
National Institute of Diabetes and Digestive and Kidney Diseases	ZIADK043012
NIH Clinical Center
Conselho Nacional de Desenvolvimento Científico e Tecnológico	405053/2013-4

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cancer
Immunotherapy
Parathyroid

Access to Document

10.1007/s12020-019-02136-z

Cite this

@article{e112c50538294ddeb6ffca542a4fd4f2,

title = "Long-term remission of disseminated parathyroid cancer following immunotherapy",

abstract = "Purpose: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered. Subject and results: A patient with CDC73-associated metastatic parathyroid carcinoma was treated with combined anti-hPTH immunotherapy and surgery. Conclusions: Following five courses of anti-hPTH immunotherapy and subsequent surgery, a 12-year long remission of disseminated parathyroid cancer is reported. This case further supports the ever-expanding spectrum of cancers that may benefit from immunotherapy.",

keywords = "Cancer, Immunotherapy, Parathyroid",

author = "Marta Sarquis and Marx, \{Stephen J.\} and Albert Beckers and Bradwell, \{Arthur R.\} and Simonds, \{William F.\} and Bicalho, \{Maria Aparecida C.\} and Daly, \{Adrian F.\} and Daniela Betea and Eitan Friedman and \{De Marco\}, Luiz",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/s12020-019-02136-z",

language = "אנגלית",

volume = "67",

pages = "204--208",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Long-term remission of disseminated parathyroid cancer following immunotherapy

AU - Sarquis, Marta

AU - Marx, Stephen J.

AU - Beckers, Albert

AU - Bradwell, Arthur R.

AU - Simonds, William F.

AU - Bicalho, Maria Aparecida C.

AU - Daly, Adrian F.

AU - Betea, Daniela

AU - Friedman, Eitan

AU - De Marco, Luiz

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Purpose: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered. Subject and results: A patient with CDC73-associated metastatic parathyroid carcinoma was treated with combined anti-hPTH immunotherapy and surgery. Conclusions: Following five courses of anti-hPTH immunotherapy and subsequent surgery, a 12-year long remission of disseminated parathyroid cancer is reported. This case further supports the ever-expanding spectrum of cancers that may benefit from immunotherapy.

AB - Purpose: Parathyroid cancer is a rare tumor associated with poor prognosis particularly when disseminated. While chemotherapy and/or radiotherapy are of no clinical value in disseminated disease, immunotherapy should be considered. Subject and results: A patient with CDC73-associated metastatic parathyroid carcinoma was treated with combined anti-hPTH immunotherapy and surgery. Conclusions: Following five courses of anti-hPTH immunotherapy and subsequent surgery, a 12-year long remission of disseminated parathyroid cancer is reported. This case further supports the ever-expanding spectrum of cancers that may benefit from immunotherapy.

KW - Cancer

KW - Immunotherapy

KW - Parathyroid

UR - https://www.scopus.com/pages/publications/85075692684

U2 - 10.1007/s12020-019-02136-z

DO - 10.1007/s12020-019-02136-z

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

C2 - 31782130

AN - SCOPUS:85075692684

SN - 1355-008X

VL - 67

SP - 204

EP - 208

JO - Endocrine

JF - Endocrine

IS - 1

ER -

Long-term remission of disseminated parathyroid cancer following immunotherapy

Abstract

Funding

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this